Stimulant drug abuse is highly prevalent, constituting a major public health concern. To gain better insight into mechanisms contributing to stimulant drug abuse, the neurochemical mechanisms subserving the behavioral effects of these drugs have been intensively examined. Neurochemically, these drugs increase synaptic concentrations of dopamine (DA) and norepinephrine (NE). Evidence indicates that actions of DA within the striatum and nucleus accumbens are critical components of the rewarding and locomotor activating effects of stimulants. It is generally believed that NE serves a minimal contributory role in these behavioral actions of stimulants. However, recent observations by the PI indicate that previous studies may not have adequately addressed this issue. The rewarding effects of these drugs are superimposed upon an alert behavioral state (e.g. prolonged periods of waking/enhanced alertness). The ability of stimulants to maintain waking and enhance alertness has long been exploited and is a contributing factor to the widespread use of these drugs. However, the degree to which NE or DA participates in the """"""""arousal""""""""-enhancing actions of stimulants and which anatomical site(s) subserve such actions remains enigmatic. A variety of observations suggest that noradrenergic systems participates in the modulation of behavioral state. Previous studies by the PI demonstrated potent actions of the locus coeruleus (LC) on EEG and behavioral indices of waking via actions of beta-receptors located within structures located within the medial basal forebrain. Additional studies demonstrated potent arousal-enhancing effects of amphetamine when infused into these regions. These observations suggest that at least some of the arousal-enhancing actions of stimulants may be due to enhanced release of NE within the basal forebrain. Utilizing a combination of behavioral, pharmacological, and anatomical methods, the proposed studies will provide novel information concerning the degree to which NE participates in the behavioral effects of stimulants and the receptor mechanisms and circuitry involved in these actions. Information obtained in these studies may provide insight into mechanisms subserving, and treatment of, stimulant drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA010681-09
Application #
6841601
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (01))
Program Officer
Frankenheim, Jerry
Project Start
1997-02-10
Project End
2006-11-30
Budget Start
2004-12-01
Budget End
2006-11-30
Support Year
9
Fiscal Year
2005
Total Cost
$252,000
Indirect Cost
Name
University of Wisconsin Madison
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
España, Rodrigo A; Schmeichel, Brooke E; Berridge, Craig W (2016) Norepinephrine at the nexus of arousal, motivation and relapse. Brain Res 1641:207-16
Schmeichel, Brooke E; Berridge, Craig W (2014) Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. Int J Neuropsychopharmacol 17:63-75
Schmeichel, Brooke E; Berridge, Craig W (2013) Wake-promoting actions of noradrenergic ?1 - and ?-receptors within the lateral hypothalamic area. Eur J Neurosci 37:891-900
Berridge, Craig W; Schmeichel, Brooke E; España, Rodrigo A (2012) Noradrenergic modulation of wakefulness/arousal. Sleep Med Rev 16:187-97
Stalnaker, Thomas A; España, Rodrigo A; Berridge, Craig W (2009) Coping behavior causes asymmetric changes in neuronal activation in the prefrontal cortex and amygdala. Synapse 63:82-5
Devilbiss, David M; Berridge, Craig W (2008) Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 64:626-35
Berridge, Craig W (2008) Noradrenergic modulation of arousal. Brain Res Rev 58:1-17
Vittoz, Nicole M; Schmeichel, Brooke; Berridge, Craig W (2008) Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. Eur J Neurosci 28:1629-40
Berridge, Craig W (2006) Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31:2332-40
Berridge, Craig W; Devilbiss, David M; Andrzejewski, Matthew E et al. (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-20

Showing the most recent 10 out of 28 publications